Vir Biotechnology, Inc. (VIR) Moves to Strong Buy: Rationale Behind the Upgrade

Retrieved on: 2024-06-28 19:45:13

Tags for this article:

Click the tags to see associated articles and topics

Vir Biotechnology, Inc. (VIR) Moves to Strong Buy: Rationale Behind the Upgrade. View article details on hiswai:

Excerpt

Vir Biotechnology, Inc. (VIR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings ...

Article found on: nz.news.yahoo.com